Delivery Order SPE2DB22D2206-SPE2DB24FKA65
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The total ceiling value of the contract is $1,251.23 and the ultimate completion date is June 5, 2025. This is an unrestricted contract with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIALML, a pharmaceutical product, with a ceiling value of $1,035.90 and a completion date of May 30, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medical product, with a ceiling value of $7,484.43 and a period of performance through May 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. This award is associated with a larger...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564090046 - Glycopyrrolate 0.2 mg/ml Vial/ml. The contract has a ceiling value of $7,016.45 and a period of performance through March 28, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of 4,564,054,166 units of the drug glycopyrrolate 0.2 mg/ml in 20 ml vials, with a ceiling value of $1,576.96 and a performance period through March 25, 2024. This delivery order is issued under a larger indefinite delivery contract...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,050.14, is for the delivery of 4 mg/20 ml vials of the medication glycopyrrolate. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,764.01, is for the supply of the medication glycopyrrolate 1 mg/5 ml vial 5 ml. The contract is a firm fixed-price delivery order with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564228475 - Glycopyrrolate 0.2 mg/ml vial, 20ml, with a ceiling value of $2,156.27 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,539.83, is for the supply of 4563402308 - Glycopyrrolate 0.5 mg/mL vials. The contract type is Firm Fixed Price and has an ultimate completion date of January 23, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...